We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest market close, Walgreens Boots Alliance (WBA - Free Report) reached $11.20, with a -0.44% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.41% for the day. Elsewhere, the Dow gained 0.08%, while the tech-heavy Nasdaq added 0.67%.
Shares of the largest U.S. drugstore chain have appreciated by 2.46% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 5.64% and the S&P 500's gain of 6.13%.
The investment community will be closely monitoring the performance of Walgreens Boots Alliance in its forthcoming earnings report. On that day, Walgreens Boots Alliance is projected to report earnings of $0.34 per share, which would represent a year-over-year decline of 46.03%. Alongside, our most recent consensus estimate is anticipating revenue of $36.66 billion, indicating a 0.85% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.66 per share and a revenue of $151.49 billion, demonstrating changes of -42.36% and +2.59%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Walgreens Boots Alliance. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Walgreens Boots Alliance presently features a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Walgreens Boots Alliance has a Forward P/E ratio of 6.77 right now. This indicates a premium in contrast to its industry's Forward P/E of 5.43.
Investors should also note that WBA has a PEG ratio of 1.35 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 0.79 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 3, putting it in the top 2% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest market close, Walgreens Boots Alliance (WBA - Free Report) reached $11.20, with a -0.44% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.41% for the day. Elsewhere, the Dow gained 0.08%, while the tech-heavy Nasdaq added 0.67%.
Shares of the largest U.S. drugstore chain have appreciated by 2.46% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 5.64% and the S&P 500's gain of 6.13%.
The investment community will be closely monitoring the performance of Walgreens Boots Alliance in its forthcoming earnings report. On that day, Walgreens Boots Alliance is projected to report earnings of $0.34 per share, which would represent a year-over-year decline of 46.03%. Alongside, our most recent consensus estimate is anticipating revenue of $36.66 billion, indicating a 0.85% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.66 per share and a revenue of $151.49 billion, demonstrating changes of -42.36% and +2.59%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Walgreens Boots Alliance. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Walgreens Boots Alliance presently features a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Walgreens Boots Alliance has a Forward P/E ratio of 6.77 right now. This indicates a premium in contrast to its industry's Forward P/E of 5.43.
Investors should also note that WBA has a PEG ratio of 1.35 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 0.79 based on yesterday's closing prices.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 3, putting it in the top 2% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow WBA in the coming trading sessions, be sure to utilize Zacks.com.